Literature DB >> 20850420

Differential effects of adenosine A1 receptor on pain-related behavior in normal and nerve-injured rats.

Qing-Juan Gong1, Yu-Ying Li, Wen-Jun Xin, Xu-Hong Wei, Yue Cui, Jun Wang, Yong Liu, Cui-Cui Liu, Yong-Yong Li, Xian-Guo Liu.   

Abstract

This study investigated the effects of N6-cyclopentyladenosine (CPA), a potent and selective adenosine A1 receptor (A1R) agonist in normal and nerve-injured rats and mechanisms of its action by behavioral tests and electrophysiological technique. The results showed: (1) In normal rats, intraperitoneal administration of CPA (1mg/kg) increased paw withdrawal latencies, in a way blocked by a selective A1R antagonist 8-cyclopentyl-1, 3-dipropylxanthine (DPCPX, 3mg/kg, i.p.), but had no influence on the threshold of mechanical stimulation. (2) In rats with neuropathic pain induced by spinal nerve ligation (SNL), CPA reduced thermal hyperalgesia and mechanical allodynia, which could last 6h and 10h, respectively (n=6/group, P<0.05). Both of the effects could be blocked by pretreatment of DPCPX intraperitoneally. (3) The baseline of C-fiber but not A-fiber evoked field potentials was depressed by spinal application of CPA (0.01 mM), and this effect was prevented by application of DPCPX (0.02 mM) 30 min before CPA. (4) Spinal application of CPA depressed long-term potentiation (LTP) of A- and C-fiber evoked field potentials, and both the depression could be blocked by pretreatment of DPCPX 30 min before CPA. These results suggested that the activation of A1R has different influences on normal and neuropathic rats probably due to the absence and presence of central sensitization in spinal dorsal horn.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20850420     DOI: 10.1016/j.brainres.2010.09.034

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  16 in total

1.  Glial Activation, A Common Mechanism Underlying Spinal Synaptic Plasticity?

Authors:  Li-Jun Zhou; Xian-Guo Liu
Journal:  Neurosci Bull       Date:  2016-12-19       Impact factor: 5.203

2.  Paeoniflorin exerts analgesic and hypnotic effects via adenosine A1 receptors in a mouse neuropathic pain model.

Authors:  Dou Yin; Yuan-Yuan Liu; Tian-Xiao Wang; Zhen-Zhen Hu; Wei-Min Qu; Jiang-Fan Chen; Neng-Neng Cheng; Zhi-Li Huang
Journal:  Psychopharmacology (Berl)       Date:  2015-10-29       Impact factor: 4.530

Review 3.  The Importance of astrocyte-derived purines in the modulation of sleep.

Authors:  Tamara Blutstein; Philip G Haydon
Journal:  Glia       Date:  2012-10-01       Impact factor: 7.452

4.  Antidepressant activity of the adenosine A2A receptor antagonist, istradefylline (KW-6002) on learned helplessness in rats.

Authors:  Koji Yamada; Minoru Kobayashi; Shizuo Shiozaki; Teruko Ohta; Akihisa Mori; Peter Jenner; Tomoyuki Kanda
Journal:  Psychopharmacology (Berl)       Date:  2014-02-02       Impact factor: 4.530

5.  The effects of opioid receptor antagonists on electroacupuncture-produced anti-allodynia/hyperalgesia in rats with paclitaxel-evoked peripheral neuropathy.

Authors:  Xianze Meng; Yu Zhang; Aihui Li; Jiajia Xin; Lixing Lao; Ke Ren; Brian M Berman; Ming Tan; Rui-Xin Zhang
Journal:  Brain Res       Date:  2011-08-07       Impact factor: 3.252

Review 6.  Identification of A3 adenosine receptor agonists as novel non-narcotic analgesics.

Authors:  K Janes; A M Symons-Liguori; K A Jacobson; D Salvemini
Journal:  Br J Pharmacol       Date:  2016-03-06       Impact factor: 8.739

7.  The role of peripheral adenosine receptors in glutamate-induced pain nociceptive behavior.

Authors:  S J Macedo-Júnior; F P Nascimento; M Luiz-Cerutti; A R S Santos
Journal:  Purinergic Signal       Date:  2021-04-16       Impact factor: 3.765

8.  Enhanced hippocampal long-term potentiation and fear memory in Btbd9 mutant mice.

Authors:  Mark P DeAndrade; Li Zhang; Atbin Doroodchi; Fumiaki Yokoi; Chad C Cheetham; Huan-Xin Chen; Steven N Roper; J David Sweatt; Yuqing Li
Journal:  PLoS One       Date:  2012-04-19       Impact factor: 3.240

Review 9.  Long-term potentiation in spinal nociceptive pathways as a novel target for pain therapy.

Authors:  Ruth Ruscheweyh; Oliver Wilder-Smith; Ruth Drdla; Xian-Guo Liu; Jürgen Sandkühler
Journal:  Mol Pain       Date:  2011-03-28       Impact factor: 3.395

10.  Gliotransmission modulates baseline mechanical nociception.

Authors:  Jeannine C Foley; Sally R McIver; Philip G Haydon
Journal:  Mol Pain       Date:  2011-12-02       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.